Senti Biosciences, Inc.

NasdaqCM:SNTI Stock Report

Market Cap: US$9.7m

Senti Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of SNTI?
Owner TypeNumber of SharesOwnership Percentage
Institutions370,8878.1%
Individual Insiders373,9818.17%
Public Companies587,84912.8%
VC/PE Firms696,37015.2%
General Public2,549,89255.7%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.8%.

Top Shareholders

Top 19 shareholders own 44.31% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
12.8%
Bayer Aktiengesellschaft
587,849US$1.2m0%no data
9.67%
New Enterprise Associates, Inc.
442,615US$938.3k0%0.04%
5.54%
8VC
253,755US$538.0k0%0.6%
4.25%
Omid Farokhzad
194,740US$412.8k0%no data
3.86%
ARK Investment Management LLC
176,666US$374.5k11.4%no data
3.53%
Timothy Lu
161,628US$342.7k0%no data
2.13%
The Vanguard Group, Inc.
97,467US$206.6k37.9%no data
1.05%
Intel Capital Corporation
48,048US$101.9k-19.3%0.01%
0.6%
Geode Capital Management, LLC
27,293US$57.9k11.1%no data
0.38%
James Collins
17,613US$37.3k0%no data
0.23%
UBS Asset Management AG
10,497US$22.3k0%no data
0.087%
BlackRock, Inc.
4,004US$8.5k-0.02%no data
0.052%
Tower Research Capital Europe Limited
2,359US$5.0k518%no data
0.033%
Harbour Investments, Inc.
1,500US$3.2k0%no data
0.032%
Sanctuary Advisors, LLC
1,470US$3.1k0%no data
0.012%
Morgan Stanley, Investment Banking and Brokerage Investments
566US$1.2k5.01%no data
0.011%
Barclays Bank PLC, Securities Investments
500US$1.1k0%no data
0.0077%
Bank of America Corporation, Asset Management Arm
351US$744.6328%no data
0.0036%
Citigroup Inc.,Banking and Securities Investments
166US$352.40%no data